Antisense Flashcards

1
Q

What is Antisense RNA?

A

Strong strands of nucleic acids that bind mRNA and change the behaviour (degrade/supress translation etc) and affect protein production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the main types of antisense?

A

Oligodioxynucelotides (AO)
Ribozymes
RNAi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What steps can we regulate?

A
Processing (splicing, polyadenylation, capping)
Editing
Nuclear Export
Localization
Protein degradation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the key stage of translation that we can regulate?

A

Initiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does initiation work?

A

Binding of initiation complex (eIF4 a, b, g, e) with preinitiation complex to the 5’ cap (modified guanine)

Scans down until it reaches AUG (start codon) - recruits 60S ribosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is mRNA circularisation?

A

eIF4E/G bind PABPI on 3’ polyA tail - circularisation of mRNA - recycling ribosomes - ensures only intact mRNA are transcribed (with polyA tail)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some examples of natural AO?

A

MSX-1 - Murine tooth development

Frq - circadian rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some examples of therapeutic AO?

A

Thallasaemia - Mutation in intron 2 - insertion of a cryptic splice site - insertion of intron 2 in final mRNA - leads to truncated B-globin protein. AO can bind to intron 2 and prevent insertion of cryptic splice site - prevents insertion of intron 2 - normal protein

DMD - Mutation in exon 23 - nonsense mutation (C-T = STOP codon) - leads to truncated Dystrophin - AO binds to exon 23 and stops it being included in final mRNA - short but functional dystrophin protein.

SMA - Mutation in exon7 - prevention of SF2/ASF binding to ESE - truncated unstable protein - AO binds ESE and recruits SF2/ASF - normal protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the problems with antisense?

A

RNA unstable
Difficult to get into cell
Cell natural mechanisms to target antisense for degradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can we modify AO?

A

Modified Ribose - add methyl/sulphur groups onto phosphate - prevent recognition by cell

Modified Backbone - change sugar/phosphate backbone to peptide backbone - prevent recognition and reduce charge so easier to get into cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some additional examples of AO as therapeutics?

A

Genasense - BCL-2 - CLL/Breast cancer

Gem92 - HIV Gag (proteins in assembly and vision function) - AIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a ribozyme?

A

RNA enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some types of ribozyme?

A

RNAse P
Group 1 and 2 Introns
Hammerhead (plant virus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are aptamers?

A

Short RNA sequences that can bind specific substrate (e.g. peptide) and block its activity (e.g. catalytic function)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do we produce aptamers?

A

SELEX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is an example of an aptamer for therapeutic use?

A

TAR decoy aptamer - binds TAT - inhibits gene expression - HIV

17
Q

What are some uses of aptamers?

A

Diagnostics
Target validation
High Throughput screening
Therapeutics

18
Q

What are the two classes of RNAi?

A

siRNA

miRNA

19
Q

What are siRNAs?

A

21-23 nucleotides
Perfect complimentary - degradation
Viral defence mechanisms

20
Q

What are miRNAs?

A

21-23 nucleotides
Imperfect complimentary - suppression of translation
Gene regulation

21
Q

How are miRNAs produced?

A

miRNA genes transcribed in nucleus by RNA Pol II to produce pre-miRNA

Pre-miRNA cleaved by Drosha and exported from nucleus via exportin 5

Cleaved by Dicer enzyme to produce miRNA

Combined with Argonaute complex to produce RISC

Targets mRNA with imperfect complimentary binding - translational supression

22
Q

How are siRNAs produced?

A

dsRNA in cell is degraded by Dicer enzyme

siRNA combine with Argonaute to produce RISC

Ago2 cleaves passenger strand

siRISC binds with perfect complimentarity to mRNA and causes degradation

23
Q

What is the origin of dsRNA within the cell?

A

Immune defence against virus and transposons

24
Q

What are the domains of the DICER enzyme?

A

PAZ domain - recognises 3’ of dsRNA and positions for 21-23 nucleotide cleavage

RNAse domain - cleavage of dsRNA - contains two catalytic sites for both strands - Mn divalent cation containing

25
Q

What is the RISC complex?

A

RNA induced silencing complex - contains Argonaute complex as catalytic component

26
Q

What are the domains of the Argo complex?

A

PAZ - recognises 3’ RNA and positions miRNA

PIWI domain - cleaves mRNA (siRNA) or suppresses (miRNA )

27
Q

How does mRNA suppress translation?

A

Two step - Translation block + Turnover

miRISC complex binds 3’ UTR of mRNA and recruits GW182 which blocks 60S ribosome binding and recruits deadeylation complex

Deadenylation beings degradation process - recruits decapping proteins - lose 5’ cap - lose initiation complex

mRNA degraded from 5’ using XRN1

28
Q

What is an example of a multiple approach method of antisense?

A

HIV

Aptamer - u6 TAR decoy - target TAT and stop HIV gene expression

Ribozyme - target CCR5 mRNA for cleavage - slows down disease

siRNA - targets REV - inhibits HIV

29
Q

What is the next phase of the HIV therapy?

A

Use of an aptamer that targets CCR5 and contains a siRNA which targets REV - single therapy